Patents by Inventor Frederic Laurent Cordier

Frederic Laurent Cordier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KRAS INHIBITORS
    Publication number: 20240368193
    Abstract: The present invention provides compounds of the formula: wherein A, Z, G, R1, R2, and R4 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer.
    Type: Application
    Filed: March 29, 2024
    Publication date: November 7, 2024
    Inventors: Adedoyin David ABRAHAM, Alberto VALERO DE LA CRUZ, Alicia MARCOS LLORENTE, Alvaro ENRIQUEZ GARCIA, Andrew DILGER, Deqi GUO, Desta BUME, Frederic LAURENT CORDIER, Gaiying ZHAO, Isabel ROJO GARCIA, James Robert HENRY, Jason Eric LAMAR, Jolie Anne BASTIAN, Maria Lourdes PRIETO VALLEJO, Mario BARBERIS, Matthew Patrick BAUMGARTNER, Miguel GARZÓN SANZ, Pablo GARCIA LOSADA, Ramkumar RAJAMANI, Richard Duane JOHNSTON, Robert HAZLITT, Santiago CARBALLARES MARTIN, Sean ARONOW, Shane Michael WALLS, Sonia Maria GUTIERREZ SANFELICIANO, Steven ANDREWS, Timothy Scott KERCHER, Victoriano MOLERO FLÓREZ, Wenceslao LUMERAS AMADOR, William Rush SCAGGS, Juan Antonio RINCON CABEZUDO, Julián PRIEGO SOLER, Xiaohong CHEN
  • MCH receptor antagonists
    Patent number: 7838543
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar1, L1, R1, q, X, R2, R3, R4, and R5 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: November 23, 2010
    Assignee: Eli Lilly and Company
    Inventors: James Peter Beck, Brian David Wakefield, Frederic Laurent Cordier, Esteban Dominguez-Manzanares, Kevin Matthew Gardinier, Peter Michael Greenen, Kenneth Allen Savin
  • NOVEL MCH RECEPTOR ANTAGONISTS
    Publication number: 20090170913
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar1, L1, R1, q, X, R2, R3, R4, and R5 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Application
    Filed: December 16, 2005
    Publication date: July 2, 2009
    Inventors: James Peter Beck, Brian David Wakefield, Frederic Laurent Cordier, Esteban Dominguez-Manzanares, Kevin Matthew Gardinier, Peter Michael Greenen, Kenneth Allen Savin
  • AMPA receptor potentiators
    Patent number: 7393868
    Abstract: The present invention relates to AMPA receptor potentiators of Formula I: formulations comprising them, methods for their use, and intermediates useful for their preparation.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: July 1, 2008
    Assignee: Eli Lilly and Company
    Inventors: Ana Maria Castano Mansanet, Frederic Laurent Cordier, Esteban Dominguez-Manzanares, Jian Eric Hong, William Joseph Hornback, Delu Jiang